Rua snaps up Zalm, and Aussie supply deal

Rua snaps up Zalm, and Aussie supply deal
Zalm chair Rob Fyfe: creating NZ's premier cannabis company. (Image: Supplied))
Staff reporters
Rua Bioscience will issue $10 million in shares at 41 cents a share to acquire Zalm Therapeutics, giving it fast track access into Australian-made product.Zalm was registered in 2018 and lists Australian medicinal cannabis company Cann subsidiary Botanitech as an 8.4% shareholder. Victoria-based Cann has research and cultivation facilities in Melbourne and is in the final stage of commissioning one of Australia's largest indoor growing facilities at Mildura, Victoria, expected to begin production in January.A core part of the acquisition is...